News + Filings Transactions
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
|
|
Holmes Scott A
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 12/13/2018 |
4
| Holmes Scott A (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Disposed/sold 162,956 shares
@ $0
Disposed/sold 902,500 options
@ $0 |
|
| 11/16/2018 |
4
| Holmes Scott A (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 1,155 shares
@ $2.77, valued at
$3.2k
|
|
| 10/30/2018 |
4
| Holmes Scott A (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 1,254 shares
@ $3.07, valued at
$3.8k
|
|
| 08/16/2018 |
4
| Holmes Scott A (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 1,185 shares
@ $3.04, valued at
$3.6k
|
|
| 07/31/2018 |
4
| Holmes Scott A (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 2,354 shares
@ $3.86, valued at
$9.1k
|
|
| 05/16/2018 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/01/2018 |
4
| Holmes Scott A (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 2,407 shares
@ $4.67, valued at
$11.2k
|
|
| 03/22/2018 |
4
| Holmes Scott A (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Granted 41,250 shares
@ $0
Granted 82,500 options to buy
@ $4.16, valued at
$343.2k
|
|
| 02/16/2018 |
4
| Holmes Scott A (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 5,651 shares
@ $4.81, valued at
$27.2k
|
|
| 01/31/2018 |
4
| Holmes Scott A (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 2,830 shares
@ $4.81, valued at
$13.6k
|
|
| 10/31/2017 |
4
| Holmes Scott A (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 2,582 shares
@ $6.03, valued at
$15.6k
|
|
| 07/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/03/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 05/01/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 03/15/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 01/31/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 10/31/2016 |
4
| Holmes Scott A (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 1,237 shares
@ $4.44, valued at
$5.5k
|
|
| 08/02/2016 |
4
| Holmes Scott A (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 4,935 shares
@ $7.36, valued at
$36.3k
|
|
| 02/01/2016 |
4
| Holmes Scott A (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Granted 53,750 shares
@ $0
Granted 107,500 options to buy
@ $3.35, valued at
$360.1k
|
|
| 11/05/2015 |
4
| Holmes Scott A (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Bought 3,672 shares
@ $5.299, valued at
$19.5k
Bought 1,328 shares
@ $5.4, valued at
$7.2k
|
|
| 08/24/2015 |
4
| Holmes Scott A (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Bought 5,000 shares
@ $5.718, valued at
$28.6k
|
|
| 08/03/2015 |
4
| Holmes Scott A (CFO) has filed a Form 4 on KERYX BIOPHARMACEUTICALS INC|
Txns:
| Sold 2,758 shares
@ $7.87, valued at
$21.7k
|
|
| 06/17/2015 |
4
| Holmes Scott A (SVP, Finance and Treasurer) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Sold 1,346 shares
@ $66.63, valued at
$89.7k
Sold 6,234 shares
@ $66.63, valued at
$415.4k
Exercised 2,734 options to buy
@ $14.89, valued at
$40.7k
Exercised 3,500 options to buy
@ $16.55, valued at
$57.9k
|
|
| 06/17/2015 |
4/A
| Holmes Scott A (SVP, Finance and Treasurer) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Exercised 3,750 options to buy
@ $14.38, valued at
$53.9k
Exercised 12,891 options to buy
@ $14.89, valued at
$191.9k
Exercised 5,875 options to buy
@ $21.13, valued at
$124.1k
|
|
| 06/05/2015 |
4
| Holmes Scott A (SVP, Finance and Treasurer) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Sold 22,516 shares
@ $68.88, valued at
$1.6M
|
|
| 03/05/2015 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 02/27/2015 |
4
| Holmes Scott A (SVP, Chief Accounting Officer) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Granted 5,000 shares
@ $0
Granted 10,000 options to buy
@ $49.46, valued at
$494.6k
|
|
| 12/18/2014 |
4
| Holmes Scott A (SVP, Chief Accounting Officer) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Paid exercise price by delivering 859 shares
@ $40.49, valued at
$34.8k
|
|
| 08/21/2014 |
4
| Holmes Scott A (SVP, Chief Accounting Officer) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Granted 5,000 shares
@ $0
Granted 15,000 shares
@ $0 |
|
| 06/11/2014 |
4
| Holmes Scott A (SVP, Chief Accounting Officer) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Granted 15,000 shares
@ $0
Granted 30,000 options to buy
@ $17.86, valued at
$535.8k
|
|
| 02/28/2014 |
4
| Holmes Scott A (VP, Chief Accounting Officer) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Granted 3,100 shares
@ $0
Granted 18,800 options to buy
@ $21.13, valued at
$397.2k
|
|
| 12/17/2013 |
4
| Holmes Scott A (VP, Chief Accounting Officer) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Paid exercise price by delivering 654 shares
@ $23.23, valued at
$15.2k
|
|
| 03/04/2013 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |
| 12/06/2012 |
4
| Holmes Scott A (Chief Accounting Officer) has filed a Form 4 on AMAG PHARMACEUTICALS INC.|
Txns:
| Sold 2,500 shares
@ $14.79, valued at
$37k
Exercised 2,500 restricted stock units
@ $0 |
|
|
|
|